Medifast (FRA:MDF) Moat Score: 5/10 (As of Jun. 28, 2026)


FRA:MDF Medifast Inc FRA:MDF
70 GF Score
Price €8.44
GF Value €7.03
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast Moat Score?

Medifast FRA:MDF -7.25% 70 Moat Score is 5 as of Jun. 28, 2026. GuruFocus rates FRA:MDF with a GF Score™ of 70/100 and a GF Value™ of €7.03 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 97 Personal Services companies, Medifast ranks better than 95.88% on this metric.

Medifast has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Medifast has Narrow Moat: Medifast Inc has a solid narrow moat due to its strong brand and customer loyalty in the weight management industry. It benefits from economies of scale and a robust distribution network, but lacks significant regulatory barriers or unique intellectual property.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Medifast might have Narrow Moat - Solid narrow moat.

Medifast  (FRA:MDF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Medifast Moat Score Related Terms

FRA:MDF vs RGS, VGES, EVTK: Moat Score Comparison

For the Personal Services subindustry, Medifast's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medifast Moat Score vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Moat Score distribution charts can be found below:

* The bar in red indicates where Medifast's Moat Score falls into.


FRA:MDF
70GF Score
Medifast Inc FRA:MDF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Medifast (FRA:MDF) has a Moat Score of 5 as of Jun. 28, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Medifast ranks #4 out of 97 companies in the Personal Services industry, placing it in the top 4.1%.
Is Medifast's Moat Score too high?
Medifast's current Moat Score is 5. Based on the distribution chart, Medifast ranks #4 out of 97 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Moat Score compare to RGS and VGES?
According to the Personal Services industry distribution chart, Medifast ranks #4 out of 97 companies for Moat Score. This places Medifast in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Personal Services company?
A good Moat Score depends on the Personal Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Medifast's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (FRA:MDF) is currently considered Modestly Overvalued. The stock's GF Value™ is €7.03, compared to a current price of €8.44 — trading 20.1% above its estimated fair value. The current Moat Score is 5. Medifast's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Medifast (FRA:MDF), the current Moat Score is 5 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (FRA:MDF) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of €8.44 is trading 20.1% above its estimated GF Value™ of €7.03. GuruFocus considers Medifast to be Modestly Overvalued.

Key valuation signals for FRA:MDF:

  • Moat Score: 5
  • GF Value™: €7.03 vs. price of €8.44 (20.1% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medifast Business Description

Other Exchanges MED:USA0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
70GF Score

Get the complete analysis for FRA:MDF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.44
Price
€7.03
GF Value